#Safety and #efficacy of inhaled IBIO123 {#mAbs} for mild-to-moderate COVID-19: a randomised, double-blind, dose-ascending, placebo-controlled, phase 1/2 trial, Lancet Infect Dis., https://doi.org/10.1016/S1473-3099(23)00393-6 #research #covid19 #SARS_CoV_2 #medicine #science
#safety #efficacy #mAbs #research #COVID19 #SARS_COV_2 #medicine #Science
@failedLyndonLaRouchite
Absolutely. #mAbs are a net plus, certainly for the person.
#Omicron sublineage #BQ11 resistance to #mAbs, https://doi.org/10.1016/S1473-3099(22)00733-2
The best thing about being a #Pharmacometrician (IMHO) is that you never stop learning, and every job is different. Right now I work a lot in #Immunooncology, the use of monocolonal antibodies (#mAbs) for treating #Cancer. mAbs have their own interesting set of complexities. (Well, they're interesting after we've figured them out. Before that that they're just maddening.)
#Pharmacometrician #Immunooncology #mAbs #cancer